Some stories require more time to tell.
When I originally envisioned the AntiViral series, I saw them as brief four- to five-minute episodes designed to give viewers a clear, high-level overview of each topic. I felt a shorter format would provide an easily digestible entry point for those without the time to watch hours-long presentations. The goal was to deliver the key takeaways in both the video and accompanying description, while linking to full articles for anyone seeking deeper context. In this way, the episodes served as trailers for the information, allowing viewers to dive into the complete feature whenever they wanted more.
While this format has proven successful—and the response has been overwhelmingly positive—it comes with a trade-off. Condensing complex topics means cutting important evidence that helps present the complete picture. In some cases, omitting those key details prevents a viewer from taking the leap to explore further, doing the topic a disservice by not allowing the argument to be presented as effectively as it could be. I hit this exact limitation when attempting to convert my article, 20 Undeniable Facts About PCR Tests, into a short episode. Too much vital information was lost in translation. It became clear that certain topics require a longer format to achieve their full impact.
This realization sparked the concept for AntiViral Special Presentations. These extended episodes—aiming for roughly 30 minutes each—will give complex evidence and detailed arguments the room they need to breathe.
The first presentation covers a topic that is very personal to me: the HIV/AIDS narrative. It presents what I consider the most compelling evidence challenging the accepted hypothesis. This topic was my gateway that led me to question not only virology, but the foundational assumptions of germ “theory” itself. HIV/AIDS serves as a prime case study for the broader field; once you understand the scope of what has transpired over the past four decades, the patterns seen in other historical outbreaks and “pandemics” become unmistakable. Because this topic delivers such a critical challenge of the mainstream narrative, I refused to compromise on its scope.
Clocking in at 31 minutes and 23 seconds, this inaugural Special Presentation is equivalent to six standard AntiViral episodes combined. It took quite a few months to create, along with a considerable amount of time and money spent finding new editing approaches and visual tools to adapt the material effectively to a longer runtime. Tackling a project of this scale was a daunting task, but I am confident that the final presentation achieves what I set out to accomplish.
As such, I am treating this Special Presentation more like a movie. It is targeted for release in late October or early November.
Paid subscribers will receive a full month of early access to the feature. If you have been considering becoming a paid subscriber, now is a great time to join. Paid subscriptions are currently 25% off, giving you the opportunity to get early access to this presentation while supporting the work that makes projects like this possible.
This is my way of saying thank you to those subscribers who make it possible for me to take risks like this and experiment with new ways of presenting the information to a completely new audience. During this early-access period, paid subscribers will also have the opportunity to share their thoughts, write reviews, and provide feedback in the comments section. I genuinely want to know what you think, because the future of these Special Presentations will ultimately depend on whether you believe they are worth continuing.
If the response is positive and people enjoy this format, there are other articles and topics that could easily be expanded into future AntiViral Special Presentations.
Whether this becomes a continuing feature or remains a one-off experiment is entirely up to you.
Regardless, I hope you enjoy the upcoming presentation and find that the time, effort, and resources that went into creating it were worthwhile.
AntiViral Special Presentation: Questioning the HIV-AIDS Hypothesis — Coming Soon!